…of 3,568,550 EUR (50% EU funding and 50% co-financing). Partners: Lund University, Kajsa M. Paulsson and Erik Renström MAX IV, Marjolein Thunnissen ESS, Esko Oksanen Malmö University, Marité Cardenas Region…
…EST@maxiv.lu.se if you have queries or require support. Complete Safety Test The safety training is mandatory for gaining access to the MAX IV building. Download the reading materials for your…
…an agreement was reached to initialize the DanMAX project. The DanMAX user consortium combines 48 staff members from five major Danish universities and 17 industrial companies. The academic partners of…
…587, 2008, pages 221-226 M. Eriksson, L.-J. Lindgren, M. Sjöström, E. Wallén, L. Rivkin, A. Streun http://dx.doi.org/10.1016/j.nima.2008.01.068 Prototype soft end dipole magnet for MAX-IV, fabrication and measurements Nucl. Instr. and…
…Berzins. Publication Aljabbari A., Kihara S., Rades T., Boyd BJ., Berzins K. The Influence of Gastrointestinal Biomolecules on Solid-State Transformations in Pharmaceutical Particulates Mol Pharm. 7, 4297 (2023) 10.1021/acs.molpharmaceut.3c00442 open_in_new…
…in conjunction with a predicted rise in extreme weather events in Scandinavia due to climate change, provides momentum for more bioavailable iron to enter marine environments such as the Baltic…
…what substrates are relevant to test activity on, where small model compounds do not properly mimic the more complex cell wall,” said Johan Larsbrink, study researcher and associate professor of molecular…
…project at one or more universities you should include a priority ranking). Minimum one reference letter. Proof of English language (minimum CEFR proficiency level B2). Academic transcript, including grades for all coursework, with a transcript of…
…case at MAXESS Industry Arena: Improving metal cutting tools using X-rays. Publication L. Rogström, M. Moreno, J. M. Andersson, M. P. Johansson-Jöesaar, M. Odén, K. Klementiev, L.-Å. Näslund, M. Magnuson…
…point. However, current commercial Keap1-targeting drugs covalently inhibit Keap1, a mechanism of action that comes with a lack of selectivity, side effects, and other complications during drug development. “Through this…